May 8, 2013
Shionogi held a media seminar on “EMPATHY,” an ongoing large-scale clinical study sponsored by the company, in Tokyo on May 1. EMPATHY will investigate the usefulness of aggressive lipid-lowering by statin monotherapy in 5,000 hypercholesterolemia patients with diabetic retinopathy. It...read more